Literature DB >> 13129770

Molecular analysis of JC virus genotypes circulating among the Italian healthy population.

Elisabetta Pagani1, Serena Delbue, Roberta Mancuso, Elisa Borghi, Letizia Tarantini, Pasquale Ferrante.   

Abstract

JC virus (JCV) is an unique virus, but eight different JCV genotypes and various subtypes have been individuated, with a geographic distribution that has been described in general but still needs to be detailed. To define JCV genotype epidemiology in Italy, the authors collected urine from 211 healthy individuals living in Northern, Central, and Southern Continental Italy, and in the two main Italian islands. As screening, JCV DNA was searched using a polymerase chain reaction (PCR) designed to amplify the highly conserved large T (LT) antigen-coding region. Then, to define JCV genotype and trascriptional control region (TCR) organization, fragments of major capsid protein (VP1) and TCR region were amplified and subjected to nucleotide sequencing. The mean frequency of JCV viruria was of 46%, without differences among the four geographically divided groups and between females and males. JCV types 1 and 4 were the most frequently detected, whereas JCV type 2 was rare, and type 3 was found only in one subject. The low frequency of JCV type 2 contrasts with the reported high frequency of this subtype in progressive multifocal leukoencephalopathy (PML), and supports its specific role in PML. The data indicate that JCV genotype epidemiology in Italy is quite different from that of other European countries; moreover, differences between the various Italian regions have been observed. An unexpected high frequency of a new variant of JCV type 4 with a stable point mutation (C --> G) at nucleotide 1851 was found. Furthermore, all the urinary strains had a TCR showing an archetypal organization.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13129770     DOI: 10.1080/13550280390241269

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  28 in total

1.  Genotypes of JC virus in East, Central and Southwest Europe.

Authors:  Hansjürgen T Agostini; Alison Deckhut; David V Jobes; Rosina Girones; Günther Schlunck; Marcin G Prost; Carolina Frias; E Pérez-Trallero; Caroline F Ryschkewitsch; Gerald L Stoner
Journal:  J Gen Virol       Date:  2001-05       Impact factor: 3.891

Review 2.  A classification scheme for human polyomavirus JCV variants based on the nucleotide sequence of the noncoding regulatory region.

Authors:  P N Jensen; E O Major
Journal:  J Neurovirol       Date:  2001-08       Impact factor: 2.643

3.  Human polyomavirus JC control region variants in persistently infected CNS and kidney tissue.

Authors:  C Elsner; K Dörries
Journal:  J Gen Virol       Date:  1998-04       Impact factor: 3.891

4.  Genotype profile of human polyomavirus JC excreted in urine of immunocompetent individuals.

Authors:  H T Agostini; C F Ryschkewitsch; G L Stoner
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

5.  Pituitary neoplasia induced by expression of human neurotropic polyomavirus, JCV, early genome in transgenic mice.

Authors:  J Gordon; L Del Valle; J Otte; K Khalili
Journal:  Oncogene       Date:  2000-10-05       Impact factor: 9.867

6.  Rearrangements of archetypal regulatory regions in JC virus genomes from urine.

Authors:  H T Agostini; C F Ryschkewitsch; G L Stoner
Journal:  Res Virol       Date:  1998 May-Jun

7.  Human polyomavirus JC virus genome.

Authors:  R J Frisque; G L Bream; M T Cannella
Journal:  J Virol       Date:  1984-08       Impact factor: 5.103

8.  Detection of JC virus type 1 in peripheral lymphocytes, brain and cerebrospinal fluid from two Korean AIDS patients with progressive multifocal leukoencephalopathy.

Authors:  Byung-Hoon Jeong; Jae-Kwang Jin; Eun-Kyoung Choi; Kyung-Hoon Kim; Kang-Won Choi; Myoung-Don Oh; Ki-Chul Shin; Yong-Sun Kim
Journal:  Intervirology       Date:  2002       Impact factor: 1.763

9.  PCR detection of JC virus DNA in brain tissue from patients with and without progressive multifocal leukoencephalopathy.

Authors:  P Ferrante; R Caldarelli-Stefano; E Omodeo-Zorini; L Vago; R Boldorini; G Costanzi
Journal:  J Med Virol       Date:  1995-11       Impact factor: 2.327

Review 10.  Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. A review of the literature with a report of sixteen cases.

Authors:  J R Berger; B Kaszovitz; M J Post; G Dickinson
Journal:  Ann Intern Med       Date:  1987-07       Impact factor: 25.391

View more
  15 in total

1.  JC virus promoter/enhancers contain TATA box-associated Spi-B-binding sites that support early viral gene expression in primary astrocytes.

Authors:  Leslie J Marshall; Lisa D Moore; Matthew M Mirsky; Eugene O Major
Journal:  J Gen Virol       Date:  2011-11-09       Impact factor: 3.891

2.  Presence and expression of JCV early gene large T Antigen in the brains of immunocompromised and immunocompetent individuals.

Authors:  Serena Delbue; Emanuela Branchetti; Renzo Boldorini; Luca Vago; Pietro Zerbi; Claudia Veggiani; Sara Tremolada; Pasquale Ferrante
Journal:  J Med Virol       Date:  2008-12       Impact factor: 2.327

3.  A case of a progressive multifocal leukoencephalopathy patient with four different JC virus transcriptional control region rearrangements in cerebrospinal fluid, blood, serum, and urine.

Authors:  Serena Delbue; Giovanni Sotgiu; Daniela Fumagalli; Marilena Valli; Elisa Borghi; Roberta Mancuso; Enrico Marchioni; Renato Maserati; Pasquale Ferrante
Journal:  J Neurovirol       Date:  2005-02       Impact factor: 2.643

4.  JC virus in the Irish population: significant increase of genotype 2 in immunocompromised individuals.

Authors:  Kirsten Schaffer; Noreen Sheehy; Suzie Coughlan; Colm Bergin; William W Hall
Journal:  J Neurovirol       Date:  2006-02       Impact factor: 2.643

5.  JC virus load in cerebrospinal fluid and transcriptional control region rearrangements may predict the clinical course of progressive multifocal leukoencephalopathy.

Authors:  Serena Delbue; Francesca Elia; Camilla Carloni; Eleonora Tavazzi; Enrico Marchioni; Silvia Carluccio; Lucia Signorini; Stefano Novati; Renato Maserati; Pasquale Ferrante
Journal:  J Cell Physiol       Date:  2012-10       Impact factor: 6.384

6.  Detection of the archetypal regulatory region of JC virus from the tonsil tissue of patients with tonsillitis and tonsilar hypertrophy.

Authors:  Atsushi Kato; Tadaichi Kitamura; Tomokazu Takasaka; Takashi Tominaga; Akira Ishikawa; Huai-Ying Zheng; Yoshiaki Yogo
Journal:  J Neurovirol       Date:  2004-08       Impact factor: 2.643

7.  Analysis of variability of urinary excreted JC virus strains in patients infected with HIV and healthy donors.

Authors:  Danijela Karalic; Ivana Lazarevic; Ana Banko; Maja Cupic; Djordje Jevtovic; Tanja Jovanovic
Journal:  J Neurovirol       Date:  2017-12-14       Impact factor: 2.643

8.  Disease-modifying drugs for multiple sclerosis and JC virus expression.

Authors:  Craig S Miller; Sidney A Houff; Jason Hopper; Robert J Danaher; Julie A Gurwell; Yushun Lin; Nubia Vega; Joseph R Berger
Journal:  J Neurovirol       Date:  2012-05-15       Impact factor: 2.643

9.  JC virus detection and JC virus-specific immunity in natalizumab-treated multiple sclerosis patients.

Authors:  Roberta Mancuso; Marina Saresella; Ambra Hernis; Ivana Marventano; Cristian Ricci; Simone Agostini; Marco Rovaris; Domenico Caputo; Mario Clerici
Journal:  J Transl Med       Date:  2012-12-11       Impact factor: 5.531

10.  Association between the JC polyomavirus infection and male infertility.

Authors:  Manola Comar; Nunzia Zanotta; Eleonora Croci; Immacolata Murru; Roberto Marci; Cecilia Pancaldi; Ornella Dolcet; Stefania Luppi; Monica Martinelli; Elena Giolo; Giuseppe Ricci; Mauro Tognon
Journal:  PLoS One       Date:  2012-08-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.